These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25797360)

  • 21. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP; Young K; Winter G; Hook S; Engert J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Biosynthesis of Lipooligosaccharide from
    Jacobson AN; Choudhury BP; Fischbach MA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine adjuvant technology: from mechanistic concepts to practical applications.
    Degen WG; Jansen T; Schijns VE
    Expert Rev Vaccines; 2003 Apr; 2(2):327-35. PubMed ID: 12899582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The path to a successful vaccine adjuvant--'the long and winding road'.
    O'Hagan DT; De Gregorio E
    Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of lipopolysaccharides for the prevention of various diseases: benefit and usefulness.
    Inagawa H; Kohchi C; Soma G
    Anticancer Res; 2011 Jul; 31(7):2431-6. PubMed ID: 21873155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvants.
    Fox CB; Friede M; Reed SG; Ireton GC
    Subcell Biochem; 2010; 53():303-21. PubMed ID: 20593273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kdo2-lipid A modification in gram-negative bacteria--a review].
    Wang X
    Wei Sheng Wu Xue Bao; 2013 Feb; 53(2):111-7. PubMed ID: 23627103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teasing apart structural determinants of 'toxicity' and 'adjuvanticity': implications for meningococcal vaccine development.
    Steeghs L; Tommassen J; Leusen JH; van de Winkel JG; van der Ley P
    J Endotoxin Res; 2004; 10(2):113-9. PubMed ID: 15120002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine adjuvants: scientific challenges and strategic initiatives.
    Harandi AM; Davies G; Olesen OF
    Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M; Meeusen E
    Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
    Nordly P; Madsen HB; Nielsen HM; Foged C
    Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.
    Evans JT; Cluff CW; Johnson DA; Lacy MJ; Persing DH; Baldridge JR
    Expert Rev Vaccines; 2003 Apr; 2(2):219-29. PubMed ID: 12899573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of bacterial lipopolysaccharides as immune modulator in vaccine and drug development.
    Arenas J
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):221-35. PubMed ID: 22385116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symbiont of the stink bug Plautia stali synthesizes rough-type lipopolysaccharide.
    Kobayashi H; Kawasaki K; Takeishi K; Noda H
    Microbiol Res; 2011 Dec; 167(1):48-54. PubMed ID: 21470838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an anti-endotoxin vaccine for sepsis.
    Cross AS
    Subcell Biochem; 2010; 53():285-302. PubMed ID: 20593272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Vaccine Formulation Laboratory: a platform for access to adjuvants.
    Collin N; Dubois PM
    Vaccine; 2011 Jul; 29 Suppl 1():A37-9. PubMed ID: 21684427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
    Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
    J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.